 Home > Medical News >

Medical Research Articles

FDA approves Precigen's PRGN-3006 Research New Drug (IND) Application

 Time of Update: 2020-06-10

what cell therapy increase androgen receptors ind clinical trial role cell membrane cell express

Precigen, a of intrexon's wholly owned company, (http:// signed a new licensing agreement with Ziopharm in October , however, Precigen announced that FDA (http:// has approved its prGN-3006 re
FDA approves INBRIJA for rest treatment during Parkinson's disease shutdown

 Time of Update: 2020-06-10

ans 1 2 parvovirus fifth disease pam disease rhino disease vitamins part 1

Parkinson's disease is an progressive neurodegenerative disease caused by the gradual loss of certain neurons responsible for dopamine, which can lead to a range of symptoms, including impaired move
Intercept reaches major end in phase 3 trial of new drug Ocacic acid (OCA)

 Time of Update: 2020-06-10

liver cirrhosis images hepatitis symptoms women bumex 1 mg 10 3 soow quartz level 1

NASH is a progressive liver disease caused by excessive accumulation of fat in the liver, which can lead to chronic inflammation of the liver, trigger progressive liver fibrosis, cirrhosis, and ultim
CHMP expresses support for bluebird bio's application for listing of Genenology Zynteglo

 Time of Update: 2020-06-10

carboxyhemoglobin test acid phosphatase test saliva test test osteoarthritis vegf test

recently, bluebird bio announced that the European Medicines (http:// Authority (EMA) has expressed its support for its application for approval (MAA) for gene therapy Zynteglo (formerly Known le
FDA accepts new drug application for Kala Pharma's dry eye drug KPI-121 (0.25%)

 Time of Update: 2020-06-10

3m drug delivery systems target plastic plates what drug cymbalta used target tumbling mat target comt

dry eye disease (DED) is a chronic, intermittent, multifactorous disease that affects tear strains and eye watches and can lead to instability, inflammation, discomfort, visual impairment, and eye s
CHMP recommends approval of BioMarin's Palynziq (pegvaliase) injections for patients aged 16 and over with phenylketonuria

 Time of Update: 2020-06-10

2 3 butanediol reverse phase dpp iv enzyme potassium 20 mg hormones human body

PKU is a rare genetic disease that manifests itself at birth and has a variety of cumulative toxic effects on the brain, characterized by the inability to break down phenylalanine (Phe), an amino ac
Amin and Uber co-developed By Romosozumab with strong FDA support

 Time of Update: 2020-06-10

phase 4 trial high protein flour 4 expansion joint wellbutrin 75 mg new ideas

Osteoporosis is a disease caused by decreased bone density and quality The bones of the human body are constantly changing living tissue The process, called bone reconstruction, is that bone-breakin
FDA approves Tudorza Pressair's application for a new drug

 Time of Update: 2020-06-10

strattera drug class abilify drug class rohypnol drug spiriva drug class drug imprint

recently, the (http:// of the of the Pharmaceutical (http:// announced that the u.S Food and Drug (http:// Administration (http:// had approved a supplementto new drug (http:// applicatio
Hengrui Pharmaceutical hydrochloric acid right metamidin sodium chloride infusion supplement application has been provisionally approved by the U.S. FDA

 Time of Update: 2020-06-10

sodium chloride 23.4 fda approved epoxy function hydrochloric acid ltd ferric chloride acid

recently, Hengrui Pharmaceutical (http:// issued a notice that it has received a notice from the FDA (http:// company (http:// to the U.S FDA on the supplementary application for hydrochlori
FDA accepts new drug application for AbbVie JAK1 inhibitor upadacitinib for treatment of adult patients with rheumatoid arthritis

 Time of Update: 2020-06-10

singulair drug interactions drug withdrawal syndrome drug drawings mechanism drug resistance what drug tramadol

recently, AbbVie announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has accepted the new drug (http:// application (NDA) for the treatment of adult patients with mo
AstraZeneca's new drug farxiga3 for type 2 diabetes has positive results

 Time of Update: 2020-06-10

what function chromatin heart attack diet menu what insulin used what function blood vessels diabetes sugar chart

, a further analysi s of data from a new drug, http:// (http:// http:// ) of the of the of the of the t2-type diabetes (T2D) a , announced in the of AstraZeneca http:// company, http:// th
FDA grants AT-GAA breakthrough therapy in research to be identified as used to treat late-haired Pompeii disease

 Time of Update: 2020-06-10

overnight hair treatment mayonnaise hair treatment neosporin active ingredient human body function what function cells

Pompeii disease is a genetic lysosome setic saclic disorder caused by the absence of acid-alpha-glucosinase (GAA) AT-GAA is the first to be identified as Pompeii disease the (http:// of the FDA
Hengrui Pharmaceutical iodxaol injection application approved in Germany

 Time of Update: 2020-06-10

velcade injection bevacizumab injection make sassafras drug direct injection engine b12 im injection

recently, the of its sub- company (http:// , Cadiasun Pharma GmbH, received a letter of approval from the German Federal Pharmaceutical (http:// and the Research Institute of Medical Device
Gilead Science Day service once-time Fumaolinol proofaverve tablets approved by China's National Drug Administration

 Time of Update: 2020-06-10

what nitrate drug melatonin drug test buprenorphine drug therapeutic drug monitoring torix drug

yesterday (November 19), Gilead Sciences (NASDAQ: GILD) announced that China's National Medicines (http:// Regulatory Authority approved a one-time pvorted propofol tinoforave (Veridente ®, TAF,
Innovative original drug Jierun ®, Xirun ® listed in China

 Time of Update: 2020-06-10

ammonium dichromate formula narcolepsy treatment drugs edta full form magnesium group number http

public data show that China has a high number of patients with COPD and a low rate of disease awareness, with 13.7% of the population aged 40 and over, an increase of 67% in a decade according to s
FDA accepts new drug application from Clearside Biomedical's Xipere

 Time of Update: 2020-06-10

outer membrane vesicles lasix drug interactions phenol drug all transport water treatment methods

vyreitis is a group of inflammatory eye diseases that are one of the leading causes of vision loss, affecting about 350,000 patients in the United States and more than 1 million patients worldwide
FDAIterum Ist.

 Time of Update: 2020-06-10

urinary tract stones antibiotics treatment phase 4 clinical trial new products iodine medical use

antibiotics are a revolutionary breakthrough in the of the Medical (http:// Health (http:// which makes it possible to treat once-fatal infections However, with the spread of antibiotic use, mi
FDA approves new drug Rocklatan to reduce intra-eye pressure in open-angle glaucoma or high-eye pressure patients

 Time of Update: 2020-06-10

butalbital side effects coumadin side effects high pressure symbol apomorphine side effects turkesterone side effects

recent, the United States The FDA (http:// approved the new drug (http:// Rocklatan to reduce intra-eye pressure (IOP) in patients with open-angle glaucoma or hyper-eye pressure Rocklatan Ro
FDA accepts application for application for treatment of advanced renal cell carcinoma by Bavencio (avelumab) and Inlyta (Axitinib)

 Time of Update: 2020-06-10

different types seeds different types sunscreen 2 3 dpg crystals breast cancer hyperthermia cancer treatment

renal cell carcinoma is the most common type of kidney cancer, accounting for about 70% of patients with kidney cancer, accounting for 2% to 3% of all types of cancer patients in adults Although the
FDA approves Mercay Heavy Anti-PD-1 Therapy Keytruda For Advanced/Metastatic Non-Small Cell Lung Cancer

 Time of Update: 2020-06-10

mysoline side effects firmagon side effects chlorpheniramine side effects 1 inch 16 mitigare side effects

today, The FDA's (http:// announced approval of the heavy-duty anti-PD-1 therapy, developed by the http:// Company , , as a single-drug therapy for PD-L1-positive late-stage/metastatic non-small

Go to Page

Medical Research Articles

FDA approves Precigen's PRGN-3006 Research New Drug (IND) Application

FDA approves INBRIJA for rest treatment during Parkinson's disease shutdown

Intercept reaches major end in phase 3 trial of new drug Ocacic acid (OCA)

CHMP expresses support for bluebird bio's application for listing of Genenology Zynteglo

FDA accepts new drug application for Kala Pharma's dry eye drug KPI-121 (0.25%)

CHMP recommends approval of BioMarin's Palynziq (pegvaliase) injections for patients aged 16 and over with phenylketonuria

Amin and Uber co-developed By Romosozumab with strong FDA support

FDA approves Tudorza Pressair's application for a new drug

Hengrui Pharmaceutical hydrochloric acid right metamidin sodium chloride infusion supplement application has been provisionally approved by the U.S. FDA

FDA accepts new drug application for AbbVie JAK1 inhibitor upadacitinib for treatment of adult patients with rheumatoid arthritis

AstraZeneca's new drug farxiga3 for type 2 diabetes has positive results

FDA grants AT-GAA breakthrough therapy in research to be identified as used to treat late-haired Pompeii disease

Hengrui Pharmaceutical iodxaol injection application approved in Germany

Gilead Science Day service once-time Fumaolinol proofaverve tablets approved by China's National Drug Administration

Innovative original drug Jierun ®, Xirun ® listed in China

FDA accepts new drug application from Clearside Biomedical's Xipere

FDAIterum Ist.

FDA approves new drug Rocklatan to reduce intra-eye pressure in open-angle glaucoma or high-eye pressure patients

FDA accepts application for application for treatment of advanced renal cell carcinoma by Bavencio (avelumab) and Inlyta (Axitinib)

FDA approves Mercay Heavy Anti-PD-1 Therapy Keytruda For Advanced/Metastatic Non-Small Cell Lung Cancer